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E-mail address: gsak@med.upatras.gr (G.C. SakellaIn the rapidly advancing ﬁeld of ﬂow cytometry, methodologies facilitating automated clinical decision
support are increasingly needed. In the case of B-Chronic Lymphocytic Leukemia (B-CLL), discrimination
of the various subpopulations of blood cells is an important task. In this work, our objective is to provide a
useful paradigm of computer-based assistance in the domain of ﬂow-cytometric data analysis by propos-
ing a Bayesian methodology for ﬂow cytometry clustering.
Using Bayesian clustering, we replicate a series of (unsupervised) data clustering tasks, usually per-
formed manually by the expert. The proposed methodology is able to incorporate the expert’s knowledge,
as prior information to data-driven statistical learning methods, in a simple and efﬁcient way. We
observe almost optimal clustering results, with respect to the expert’s gold standard. The model is ﬂexible
enough to identify correctly non canonical clustering structures, despite the presence of various abnor-
malities and heterogeneities in data; it offers an advantage over other types of approaches that apply
hierarchical or distance-based concepts.
 2008 Elsevier Inc. All rights reserved.1. Background these attributes can be used to identify and characterize speciﬁcFlow cytometry is a commonly used technology in various bio-
logical and medical laboratory applications; it is able to provide
quantitative and qualitative information about single particles,
such as blood cells, nuclei, microorganisms, etc., as they ﬂow in a
ﬂuid stream through a beam of light [1]. In the past decade, ﬂow
cytometry has been extensively applied to hematological immuno-
phenotyping and corresponding diseases diagnosis, including lym-
phoma and common types of leukemia, such as B-Chronic
Lymphocytic Leukemia (B-CLL), Acute Myeloid Leukemia (AML)
and Acute Lymphoblastic Leukemia [2]. Due to its distributed nat-
ure, the hematopoietic system is amenable to ﬂow-cytometric
analysis. This analysis provides measurements of physical proper-
ties for each single blood cell; that is, its relative size, obtained by
the forward angle light scattered intensity (FS), and its relative
internal granularity or complexity, obtained by the 90-degrees
(side) angle light scattered intensity (SS). It is also able to provide
measurements of a great variety of ﬂuorescent antigen attributes
for each single cell, using the relative intensity of the light emitted
in presence of the corresponding ﬂuorescently labeled antibodies;ll rights reserved.
t of the University of Patras,
ropoulos).cell surface immunophenotypes.
While ﬂow cytometry technology is continuously evolving (in
terms of the process speeds achieved, the number of ﬂuoro-
chromes concurrently used and the simplicity of operation of the
devices deployed), the requirement for adequate automated (com-
puter-assisted) analysis methods on ﬂow-cytometric data is
accordingly increasing [3]. Currently, typical ﬂow cytometers pro-
vide only a few simplistic data analysis tools, such as histograms
(i.e., 1-parametric) and 2- or maybe 3-parametric scatter plots.
The medical expert takes into account such visual information
and performs all the remaining analysis required by hand, usually
by manually drawing rectangles and lines to select subsets of par-
ticles in the domain of interest.
Universal algorithmic techniques for the analysis of ﬂow cytom-
etrydata in themedical domainhavenotbeendevelopedyet,mainly
because examinations of patients suffering from different diseases
produce data of various properties and characteristics (shapes, het-
erogeneities, variance-covariance structures, etc.). Special-purpose
methodologies that take into account the conditions of the disease
under study, both in terms of medical or biological knowledge of
the ﬁeld and in terms of the speciﬁc heuristic approach followed
by medical experts will be required. Computer-assisted methods
in the future will provide the means for analyzing ﬂow cytometry
data directly in large-dimensional spaces, escaping the human con-
straints of analyzing the data in their 2-D or 3-D representations.
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or biological ﬂow-cytometric data is the identiﬁcation of particle
subgroups (say, cell subpopulations) in a mixed (blood) sample.
Under data-mining terms, each such instance forms a special case
of a well-deﬁned optimization problem, that is referred to as unsu-
pervised data classiﬁcation or data clustering [4]: given a set of
unlabelled elements (blood cells) along with a set of associated
vectors of attributes (measurements of ﬂuorescence and scatter),
the identiﬁcation of an optimal partition of the elements into clus-
ters (cell subpopulations) is requested, with respect to some prede-
ﬁned proximity or similarity criteria. Dependent on the
application, the actual number of clusters might or might not be
a priori known. The crucial difference between clustering and
(supervised) classiﬁcation is that in the former and much harder
case, no training data exist; i.e., no initially labeled elements
(e.g., cells initially assigned to subpopulations) are available.
Data clustering is a very complicated problem to solve (it is, in
fact, computationally NP-hard), especially when considering large-
sized heterogeneous ﬂow-cytometric data [5]. Such data are often
characterized by large sample-to-sample variations and abnormal-
ities (on the number and shape of the clusters constructed, on the
obtained intracluster structures, etc.), due to the presence of path-
ological underlying situations.
Another issue, particularly important in the medical domain, is
that the procedure that experts follow incorporates aspects of deep
knowledge of the speciﬁc domain as well as their heuristics, gained
through their experience in the ﬁeld. Thus, when experts perform
the analysis, the procedure is not entirely data-driven. Since no
training data are used, the clustering algorithm adopted must in-
clude techniques to incorporate the expert’s knowledge on the par-
ticular domain of application and provide close to optimal results
in terms of their alignment with those provided by the expert. In
other words, the only existing gold standard to compare against
is the medical doctor. Finally, any ﬂow-cytometric clustering pro-
cedure must be able to perform successfully within efﬁcient execu-
tion times; since ﬂow-cytometric data may be comprised of tens of
thousands of particles, achieving acceptable combinations on the
level of both optimality and time-efﬁciency is not a trivial issue.
In this work, we provide a paradigm of computer-based assis-
tance in the domain of ﬂow-cytometric data analysis, considering
a very important application of ﬂow cytometry in medical labora-
tories. We deal with the issue of B-CLL diagnosis and propose and
implement an automated procedure, that replicates step-by-step
the sequence of actions performed by a medical expert for that
purpose. We show that each step of the process forms a special in-
stance of data clustering and attempt to perform it on an algorith-
mic basis by applying Bayesian clustering [6]. Bayesian clustering
or, equivalently, the probabilities mixture model for clustering is
a relatively new methodology that has exhibited promising results
for clustering in other domains [7].
1.1. B-CLL diagnosis
B-CLL is known to be the most common adult leukemia type in
the Western world. Its diagnosis is considered as one of the most
important applications of ﬂow cytometry in medicine. According
to the sequence of actions performed by the medical expert, each
analysis step forms a special instance of clustering speciﬁc subpop-
ulations of leukocytes (peripheral blood cells) given a set of identi-
fying, physical or ﬂuorescent, attribute measurements. As
presented in Fig. 1(a), the expert initially distinguishes the subpop-
ulation of lymphocytes among all the cells in peripheral blood
(which can be lymphocytes, monocytes, neutrophils, etc.) by hand;
that is, he selects one of the high-density subpopulations of leuko-
cytes on the FS–SS space, the one that is characterized by smaller
size and less granularity (nearest to the left-bottom corner), bydrawing a rectangle. This manual process is usually referred to as
gating.
Next, the subpopulation of lymphocytes is distinguished into
further subgroups, based on whether they express selected B-CLL
marker antigens or not. Typical immunophenotypic ﬁndings [2]
suggest that leukemic B-lymphocytes (that is, lymphocytes that ex-
press antigens CD19 and CD20) usually also co-express antigens
CD5 and CD23, they sometimes negatively co-express antigens
CD79b and FMC-7, and are either K- (kappa) orK- (lambda) marker
positive, among others. All such subpopulation identiﬁcations obvi-
ously form special data clustering instances and are also performed
withmanual gating by the expert,whodraws rectangles and thresh-
old lines on the plots provided by the ﬂow cytometer (Fig. 1).
Finally, taking into account all the information provided by
those gating tasks (cardinality of the subpopulations identiﬁed,
means and median values of the antigen attributes for each sub-
population, etc.), the expert computes a scoring value, based on a
predeﬁned scoring system, and proceeds to the diagnosis, combin-
ing the laboratory observations with further clinical examination
ﬁndings. It is clear, however, that the main part of the process con-
sists of a sequence of gating tasks; these tasks can all be treated
uniformly and be performed automatically with the use of an efﬁ-
cient data clustering algorithm.
1.2. Flow-cytometric data clustering
Data clustering is a major problem arising in statistics and data-
mining that has been studied extensively in the past; its basic
principles are described in [4]. Some of the existing clustering algo-
rithms, however, are not applicable to ﬂow-cytometric data analy-
sis. This is mainly because ﬂow-cytometric data samples are
usually large; some of them may be comprised of tens or hundreds
of thousands of particles. When considering such large samples, all
clustering algorithms of hierarchical philosophy become extremely
inapplicable and space-inefﬁcient; this is due to the fact that such
algorithms require the continuous storage of the whole dataset to
maintain a proximity matrix among all possible particle pairs. The
same argument also applies to graph-theoretic clustering methods,
where all possible pairs of particles have to be connected via arcs,
in a way the set of particles forms a fully connected graph, and an
adjacency matrix of all particle pair distances has to be continu-
ously stored during the clustering process.
The great majority of all up-to-date proposed approaches on
ﬂow-cytometric data clustering have applied traditional linkage-
based methods, like variations of the well-known k-means algo-
rithm [8–11]. k-Means is simple and efﬁcient enough, but tends
to cluster the elements into spherical non-overlapping groups,
due to the use of the Euclidean distance as proximity metric. This
is rarely the case when considering ﬂow-cytometric data, however,
where clusters tend to be of non canonical shape and usually over-
lap each other. k-Means variants include (i) the deﬁnition of Maha-
lanobis distance as proximity metric, applied to identify different
variant–covariant structures and clusters of ellipsoid shape, (ii)
the initial request for a large number of smaller clusters, that are
ﬁnally merged into their actual number following some predeﬁned
criteria, and (iii) an initial heuristic search for the estimation of the
actual number of existing clusters and the identiﬁcation of the
optimal set of their centroids using, for example, histogram guid-
ance. An alternative type of clustering approaches for dealing with
not well-separated clusters incorporating fuzzy logic, where each
element is allowed to belong to multiple clusters, according to a
probability distribution of membership. An application of fuzzy
c-means (fcm) variations to ﬂow-cytometric data clustering is pre-
sented in [12]. Unfortunately, fcm seems to suffer from similar dis-
advantages as k-means, since both algorithms are based on
common (of linkage nature) clustering principles.
Fig. 1. Example of a set of gating instances performed manually by the medical expert during the process of B-CLL diagnosis. The expert takes into account such visual
information and performs the analysis steps by hand, drawing rectangles and lines to select subsets of particles in the domain of interest.
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ing maps (SOMs) [13] and a variant of adaptive resonance theory
(ART), called RTAC [14] have been applied for the analysis of hema-
tological ﬂow-cytometric data. In the latter paper [14], human
peripheral blood cells are clustered with the use of FS, SS and four
measured antigenic attributes, while in the former paper [13],
human peripheral blood cells are further distinguished into lym-
phocytes, monocytes and three granulocyte subpopulations. Whilethese sophisticated approaches seem to perform well on clustering
instances similar to the ones we are trying to solve in our applica-
tion (having the advantage, however, of using a larger and more
suitable set of antigenic attributes—for similar purposes—than
we do), we question their ability of incorporating expert knowl-
edge. We believe, that this ability is a very crucial advantage for
a clustering algorithm specialized on applications of such nature;
it guarantees its ﬂexibility on dealing with the arising sample-to-
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abnormalities.
In another recent work [15] support vector machines (SVMs)
are used as the dominant method in a computer-assisted diagnosis
of Acute Lymphoblastic Leukemia. SVMs are used to perform
(supervised) data classiﬁcation. That is, they initially use a labeled
dataset to train their model and sequentially apply it to predict the
unknown cluster values of an unlabelled dataset. In our case, how-
ever, the available ﬂow-cytometric data are hardly expected to be
similar from patient to patient, thus training data do not exist.
Finally, an approach similar to ours has been recently presented
in [16]. In this work, the authors apply a set of four Gaussian mix-
ture-model variants and EM algorithm to cluster two different
types of ﬂow-cytometric data; they apply their methods on the
publicly available Rituximab and GvHD datasets. These datasets
correspond to hematological diseases that are different to B-CLL
(lymphoma and graft-versus-host, respectively). Thus, initially
our approach differs from this recent work in that sense. Further-
more, the simulation studies the authors provide to evaluate their
proposed models are not actually applied to those real datasets (in
fact, their models are tested on only 3 such datasets, one of the Rit-
uximab case and two of the GvHD case). Their extensive studies are
concerned with synthetic data; each one of the proposed mixture-
model variants is used to produce a number of samples according
to an underlying distribution of Gaussian mixtures. Each one of the
proposed mixture-model variants is then used to cluster the gener-
ated samples (and, thus, also estimate the generated underlying
distributions): the sample produced by itself and the samples gen-
erated by all other variants. In addition, the generated samples are
of unrealistically small cardinalities for typical ﬂow-cytometric
applications (1000 cells).
In the following, we present our recent work that applies the
model of Bayesian clustering, as the central algorithmic concept
of an automated and fully unsupervised procedure for B-CLL diag-
nosis. Our approach is able to incorporate the expert’s suggestions
and knowledge, without however allowing his direct supervision.
Real hematological ﬂow-cytometric data were analyzed and a de-
tailed comparison with other clustering methodologies that have
been previously applied to ﬂow-cytometric data clustering is also
provided, using the same data.
2. Materials and methods
2.1. Bayesian clustering
The Bayesian clustering model assumes that the data are gener-
ated by a mixture of underlying probability distributions, with
each component representing a different cluster. Let cluster be a
discrete random variable, obtaining values according to which
cluster a randomly chosen element (blood cell) belongs to (say,
integers from 1 to k), and att1, att2, . . .,attn be a set of (generally
continuous) random variables, that represent the attribute valuesFig. 2. The induced naïve Bayesian network for clustering; all the (continuous) attribute
discrete and hidden.of the randomly chosen element. The joint probability distribution
generating the data is assumed to be Pr{cluster, att1, att2, . . .,attn}
and the probabilities mixture model is deﬁned as
Prfcluster; att1; att2; :::; attng ¼ Prfclusterg
Yn
i¼1
Prfattijclusterg: ð1Þ
The above equation implies, that if the cluster value is known, all
attribute variables are pairwise stochastically independent. By
applying simple rules of probability, the following relationship also
holds:
Prfclusterjatt1; att2; :::; attng / Prfclusterg
Yn
i¼1
Prfattijclusterg: ð2Þ
Using the last equation and given all att1, att2, . . .,attn values, one is
able to compute the most probable assignment of each element to a
cluster. That is,
cluster ¼ arg max
j¼1; :::; k
Prfcluster ¼ jg
Yn
i¼1
Prfattijcluster ¼ jg: ð3Þ
This procedure for clustering can alternatively be considered (Fig. 2)
as an inference process in a naive Bayesian network [17]. The struc-
ture of this network consists of a simple directed tree of unit depth;
variable cluster is the root of the tree, while all attribute variables
are its children. All edges are directed from the unique root to the
leaves (children). All the (continuous) attribute variables are con-
sidered to be Gaussian, while variable cluster is considered to be dis-
crete and hidden; that is, we do not know either the number of
cluster outcomes or the value of the variable cluster for the various
cells.
Were the parameters, i.e., the probability distributions Pr{clus-
ter} and Pr{atti|cluster}, of the naive Bayesian network known,
inference on the cluster values would be accomplished by simply
applying the sequence of Eqs. (1)–(3); for each cell, the probabili-
ties of each cluster outcome given the cell’s attributes would be cal-
culated and the cluster outcome with maximum probability would
be chosen. While general inference in Bayesian networks requires
exponential time, in the case of the naïve network the above de-
scribed set of operations requires linear time on the amount of
the existing attributes.
However, the cluster variable is hidden and thus the parameters
of the naïve Bayesian network can be estimated only indirectly
through the use of the Expectation-Maximization (EM) parameter
learning algorithm [6]. EM is an iterative process that yields cluster
assignments as the data approximate their maximum likelihood
value (ML), given the estimated parameters of the network. The
process iteratively assigns cluster its most probable values given
the currently estimated probability distributions (Expectation
step) and then re-estimates these distributions in order to maxi-
mize the likelihood of the data given the newly estimated param-
eters (Maximization step), until convergence is achieved. The ML
criterion is the optimization criterion of this clustering approach.variables are considered to be Gaussian, while variable cluster is considered to be
Fig. 3. The initial cluster thresholds plugged in the EM algorithm as parameter
priors for Bayesian clustering: we vertically slice the median region of CD3’s range
(where the threshold is expected to appear according to the expert’s suggestion)
into thin bins and determine as initial cluster threshold the edge of the bin
containing the minimum number of measured cells. For CD5, we perform the same
procedure, in a horizontal fashion.
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the cluster each blood cell belongs to and the (continuous) values
of its attributes. Let cluster1, cluster2, . . .,clusterm be the set of the
unknown cluster labels of the blood cells. The missing cluster la-
bels are estimated by the EM algorithm as follows: We represent
each one of them as a k-dimensional vector of indicator variables:
vc = [vc1, vc2, . . .,vck], where vcj equals to 1 if and only if the blood
cell c belongs to cluster j, otherwise equals to 0. Let also atti, c de-
note the observed value of attribute atti of blood cell c. Let, ﬁnally,
lij be the unknown mean value of the Gaussian distribution of
Pr{atti|cluster = j}. All unknown parameters Pr{cluster = j} and lij
are estimated by the EM algorithm. The Expectation step proceeds
by computing the unknown cluster labels given the current
probabilities:
vcj  
Prfclusterc ¼ jg
Qn
i¼1
Prfatti ¼ atti;cjclusterc ¼ jg:
Pk
j¼1
ðPrfclusterc ¼ jg
Qn
i¼1
Prfatti ¼ atti;cjclusterc ¼ jgÞ
: ð4Þ
The Maximization step, then, re-estimates the unknown probability
distribution parameters given the newly computed cluster labels:
mj ¼
Xm
c¼1
vcj; ð5Þ
Prfcluster ¼ jg  mj
m
; ð6Þ
lij  
Pc
j¼1
vcjatti;c
mj
: ð7Þ
Choosing the appropriate initial conditions for the EM algorithm is a
very important issue. EM is a characteristic paradigm of a hill-
climbing algorithm. It may never be able to reach the global ML va-
lue, converging instead to one of the many existing local maxima, or
it may reach the global maximum in a very slow convergence rate,
after a large number of repetitions. On the other hand, with the
choice of different initial probability parameters, the EM algorithm
may become extremely effective and efﬁcient; that is, it may con-
verge faster and more accurately to the global maximum.
In our implementation, the EM algorithm is initialized with
prior parameter values derived from a pre-processing step. If for
example we need prior values on the probability density table of
variable cluster, we need to make an initial assignment of the cells
to the requested clusters, or, in other words, select the initial
threshold values on the measured quantities (clustering attributes)
that discriminate cells between the clusters. In our application, we
identify the initial cluster thresholds using the following simple
heuristic technique (Fig. 3): for any clustering attribute, on the hor-
izontal (vertical) axis, we vertically (horizontally) slice the ele-
ments into thin bins and determine as initial cluster threshold (if
the number of requested clusters is 2) an edge of the bin containing
the minimum number of elements (measured particles), in a med-
ian selected region of the attribute’s range.
This initialization step can also be performed by utilizing a fast
and simple clustering algorithm, like k-means, or by manually
drawing initial cluster thresholds, as the expert’s opinion and the
literature on the underlying medical or biological problem suggest.
In the following, the term ‘‘expert’s opinion”—within the context of
setting attribute threshold values for clustering—and the pre-pro-
cessing step described above will be used interchangeably since
they are equivalent.
Having selected the thresholds, the data now become labeled;
we can then perform parameter learning on the naïve Bayesian
network which now has no hidden variables. For example, for
the purpose of gating the subpopulation of lymphocytes that co-
expresses antigens CD5 and CD3, we construct a Bayesian networkthat contains cluster as a root variable and CD5, CD3 as children
variables. These values become the clustering attributes of the
lymphocyte. EM execution requires an initial number of clusters
to be given by us. In our example, this would be 4, the number
of combinations of expression for the two antigens (each cell either
expresses a marker antigen or not). However, EM algorithm is ﬂex-
ible enough to identify and assign zero cluster memberships with
respect to the ML criterion; this gives us the advantage to imple-
ment fully unsupervised clustering (i.e., where the exact number
of clusters is also unknown), by initially requesting a number of
clusters larger than the one anticipated. Eq. (2) provides us with
the probability distribution for variable cluster. This constitutes
the prior distribution for the initial application of the EM
algorithm.
The above described supervised process of the initial clusters’
determination is used only for initiating the EM algorithm and
not for training the whole clustering model. The naïve-Bayes mod-
el is trained using unlabelled data; as a consequence, it performs
clustering and not (supervised) classiﬁcation.
The ability of learning the initial parameters of the induced
naïve Bayesian network with respect to any possible initial cluster-
ing conﬁguration (e.g., the expert setting the thresholds manually)
provides an excellent way for incorporating the expert’s supervi-
sion to the described method. While the diagnosis procedure re-
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offers us the opportunity to deploy ﬂexible trade-offs between
algorithmic automation and expert’s interference on each step of
the considered process.
2.2. Gating lymphocytes
During the automated B-CLL diagnosis process, the most com-
plex clustering instance arises at the ﬁrst step required in every
examined peripheral blood sample; that is, at the identiﬁcation
of the subpopulation of lymphocytes among all peripheral blood
cells, using the FS–SS plot.
Peripheral blood is mainly comprised of lymphocytes, mono-
cytes and granulocytes. Granulocytes are much more granular than
any other type of leukocytes and can easily be distinguished using
the SS attribute alone. But separating the other two leukocytic sub-
populations in the FS–SS plot, i.e., lymphocytes versus monocytes,
is not always easy since monocytes are slightly more granular than
lymphocytes and also an amount of lymphocytes is often equal-
sized to an amount of (the typically bigger) monocytes. Thus, the
clusters of monocytes and lymphocytes are often expected to over-
lap, especially along the FS axis. A theoretical solution is to apply
clustering in more dimensions, using additionally the monocyte
marker antigen CD14; in practice, unfortunately, most of the labo-
ratories do not provide such an antigen attribute, since it is not re-
quired for routine B-CLL diagnosis. Another problem, appearing in
pathological ﬂow-cytometric data samples, is that the clustering
structure of a real leukocytic population may be quite different
than the expected one, as shown in Fig. 4. A subpopulation might
be totally absent, the dead cells possibly comprise a new extra
cluster, lymphocytes might present various shape abnormalities,
etc. Therefore, in clustering peripheral blood cells under realistic
assumptions, the existing number of clusters is not always equal
to 3, but actually unknown. These characteristics imply that gating
lymphocytes directly in the FS–SS plot becomes a very complex
clustering application.
In our implementation, we overcome these difﬁculties by per-
forming lymphocytes gating in an indirect way. We take advantage
of the fact that lymphocytes are mainly subdivided into B-cells and
T-cells; for both of these subpopulations of lymphocytes there ex-
ist marker antigens, CD19 (or CD20) and CD3, respectively, that are
available in any ﬂow-cytometric B-CLL diagnosis process. For iden-
tifying B-cells and T-cells, we individually perform Bayesian clus-
tering with the use of SS and the corresponding marker attribute.
Subsequently, we merge the gated subpopulations to create an ini-
tial approximate set of identiﬁed lymphocytes. Since not all lym-
phocytes (but their great majority) are B-cells or T-cells, we
ﬁnally execute supervised Bayesian clustering in the FS–SS space
of attributes, using the previously computed set of lymphocytes
as a labeled dataset, to gate lymphocytes in all (almost identical)
peripheral blood samples of the same patient’s examination.
However, another problem arises in practice: the required anti-
gen attributes, CD3 and CD19, are often not available in a single
blood sample of the patient’s examination, but in separate ones.
Therefore, suitable distance-based techniques have to be utilized
for combining the individual gating results and achieving lympho-
cytes gating in every sample of the same examination. We utilize
the technique of k-nearest neighbors, a well-known simple algo-
rithm for supervised clustering; each cell is labeled as a lympho-
cyte or not, depending on the label of the majority of its k closest
(under Euclidean distance terms) cells on a pattern dataset. The
pattern dataset is constructed by merging the results of B-cells gat-
ing and T-cells gating, using exactly the same method. For dealing
with ‘outliers’ (that is, isolated points that can be dead cells), a
square window of maximum neighboring distance is posed, into
which all k neighbors are required to belong; therefore, the actualnumber of a cell’s neighbors is upper bounded by k and lower
bounded by the number of cells belonging into the predeﬁned
neighboring area. k-Nearest neighbors is applied to the FS–SS plot
of each sample, since the above two attributes are the only com-
mon ones in every sample of the same patient’s examination. In
[18], a precursor of this work, we give a more detailed description
of the above operations.
2.3. Evaluating performance
The proposed automated diagnosis procedure was imple-
mented using the programming environment MATLAB. We also
experimented with k-means, k-medians, fuzzy c-means and SOMs
to obtain comparative results. Using MATLAB, one of the authors
(MK) manually performed all the necessary steps for the diagnosis
of B-CLL of 30 patients, involving the manual gating on 210 periph-
eral blood samples and the measurement of clinically useful
parameters from the clustered subpopulations. Since our goal is
to automate the procedure followed by experts, we used these
clusters and the corresponding measurements as gold standard.
Our proposed method receives prior information from the expert
in the form of threshold values that deﬁne when the expression
of an antigen is considered positive or negative. For the sake of fair-
ness, we developed appropriate techniques for inserting the same
prior information to each one of the examined clustering algo-
rithms, thus avoiding any possible bias in favor of our method.
Each data sample provided was of cardinality of 10,000–40,000
cells (average 20,000 cells). Bayesian clustering was performed to
all of them, for the initial B-cell and T-cell gating which assists
us in identifying the subpopulation of lymphocytes. Antigen anal-
ysis was then performed on the latter; the minimum size of lym-
phocyte subpopulation observed was 3000 cells. All patients
suffered of B-CLL and a 7-tuple of datasets corresponded to each
patient. The 7-tuple included the control sample (FS–SS only),
the CD3 sample, the CD20–CD5 sample, the CD19–CD23 sample,
the FMC7-CD79b sample, the K sample and the K sample. Attri-
butes FS and SS were also measured in all samples. Each selected
antigen couple was strongly expressed (say, was positive in more
than 70% of the lymphocytes) in at least one sample and was
strongly negatively expressed (say, was positive in less than 30%
of the lymphocytes) in at least another sample (of another patient).
Weak antigenic expressions also appeared often. The clusters ob-
tained in the strong expression instances were usually well-sepa-
rated, while the ones obtained in the weak expression instances
were not. The executed clustering approaches were tested for their
ﬂexibility of performing accurately under all various clustering
conﬁgurations.
The performance of the various methodologies was evaluated
along two tracks. First, the clustering scores of each methodology
were calculated. The scores are expressed as average (over 30 pa-
tients) percentages of correctly clustered cells, along with the cor-
responding standard deviation. Second, for the given examinations
and for each methodology we measured speciﬁc parameters of
clinically interesting variables and present the absolute differences
from the values obtained by the expert. We then compared the
performance of Bayesian clustering to that of other clustering
methodologies using paired t-tests to investigate whether there
are signiﬁcant differences.
3. Results
The functions used for Bayesian clustering were all developed
in-house. The samples provided were of cardinalities of tens of
thousands of cells. At such large-sized datasets, clustering with
algorithms of hierarchical or graph-theoretic nature was totally
inapplicable, due to time and space inefﬁciency issues.
Fig. 4. (left) Examples of the ‘FS–SS’ plot of peripheral blood samples. The ﬁrst seems to be close to the ideal picture. In the second, lymphocytes are subdivided into two
subpopulations; thus, four subpopulations appear in total. In the third, a whole subpopulation (monocytes) is totally absent. (right) The result of gating lymphocytes in the
peripheral blood samples using our approach.
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tialize the parameters of the clustering algorithms utilized after-
wards. In the case of k-means, that was implemented as follows:
ﬁrst, the number of clusters was ﬁxed to the one determined by
the expert’s gating; then, for each cluster constructed by the ex-
pert, a centroid cell was chosen, that is, a cell with values equal
to the mean, in all attributes. Finally, k-means was initialized giventhe above computed set of centroids. Similarly, the k-medians
algorithm was initialized with centroids deﬁned by cells with val-
ues equal to the median in every attribute. Fuzzy c-means works
with the use of a membership matrix; each row of the matrix cor-
responds to a blood cell, while each column corresponds to a clus-
ter. An element of the matrix represents the probability that the
corresponding particle belongs to the corresponding cluster; the
258 J. Lakoumentas et al. / Journal of Biomedical Informatics 42 (2009) 251–261elements of each row of the matrix sum up to 1. Thus, FCMwas ini-
tialized with a membership matrix of integer values (0–1), denot-
ing full membership of every cell to a speciﬁc cluster; speciﬁcally,
the one deﬁned by the expert.
The SOM model represents the particles of the given dataset in
the form of a 2-dimensional lattice, where each blood cell corre-
sponds to a node of the lattice. By inserting the data to the model,Fig. 5. Replicating the gating instances steps shown in Fig. 1 using Bayesian clustering. F
are stepwise discriminated according to the expression of B-CLL speciﬁc antigens [see sthe weights of the edges of the lattice adapt, in a way that the
nodes corresponding to blood cells of the same cluster come closer
to each other. The data can be inserted to the model either one-by-
one (sequential mode) or all together (batch mode). We use the
former training type, since it is more convenient for inserting the
available prior information. In our experimentations, the insertion
ordering was not selected to be random, but according to the clus-ollowing the isolation of lymphocytes [step (a)—cells depicted with light gray] they
teps (b–f)].
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elements in speciﬁc regions of attribute values to be the winning
lattice nodes (i.e., the cluster centroids in the lattice conﬁguration),
we added imaginary dense clusters of elements at the beginning of
the training process and removed them at the end. The added clus-
ters appeared at symmetrical positions with regard to the expert-
deﬁned cluster thresholds. Finally, since the SOM model appeared
to be extremely sensitive to outliers (at least one of them always
tended to correspond to a winning lattice node), an extra cluster
was needed and the model was conﬁgured to assign all outliers
to that cluster. At the end, outliers were included to a cluster of a
subpopulation of cells without interest.
Whenapplyingk-means,k-medians, fuzzy c-means andSOMs for
clustering on the considered samples, we often realized that they
seemed unable to yield to near-optimal results in terms of the ex-Table 1
Average percentages of correctly clustered peripheral blood cells achieved by a variety of cl
in B-CLL diagnosis. The number of stars indicates the level of the p-value for the paired t-
Bayesian k-Means
Lymphocytes 99.6 ± 0.5 93.5 ± 8.5***
CD20+/CD5+ 96.9 ± 3.4 91.3 ± 8.9**
CD19+/CD23+ 97.7 ± 2.1 88.9 ± 14.6**
FMC7/CD79b 93.0 ± 5.9 83.8 ± 8.8***
Kappa+ 96.1 ± 2.8 83.0 ± 16.4***
Lamda+ 96.2 ± 3.5 86.6 ± 9.7***
* p < 0.05.
** p < 0.01.
*** p < 0.001.
Table 2
Average absolute differences obtained on the values of various characteristic parameters, ta
of stars indicates the level of the p-value for the paired t-test comparing each methodolog
Bayesian k-Means
Lymphocytes % 0.3 ± 0.4 6.5 ± 8.5***
CD20+/CD5+ % 4.0 ± 6.2 11.4 ± 14.4**
CD20+ Mean 24.1 ± 52.7 54.2 ± 85.8
Median 19.6 ± 55.0 49.3 ± 89.4
Peak 18.1 ± 67.7 46.2 ± 91.3
CD5+ Mean 9.7 ± 18.0 34.4 ± 60.1*
Median 10.9 ± 26.2 34.1 ± 61.1*
Peak 22.1 ± 44.5 42.3 ± 73.7
CD19+/CD23+ % 2.8 ± 2.7 15.0 ± 20.8**
CD19+ Mean 3.2 ± 4.5 26.1 ± 60.9
Median 1.9 ± 3.2 25.7 ± 59.2*
Peak 9.6 ± 19.7 55.2 ± 128.9
CD23+ Mean 4.9 ± 3.5 80.7 ± 146.9**
Median 4.0 ± 3.1 77.9 ± 149.8*
Peak 2.7 ± 9.2 75.5 ± 155.6*
FMC7/cd79B % 6.7 ± 8.3 21.6 ± 13.3***
FMC7 Mean 11.6 ± 8.2 38.7 ± 22.8***
Median 21.4 ± 17.9 45.3 ± 34.6**
Peak 0.0 ± 0.0 0.0 ± 0.0
CD79b Mean 10.5 ± 12.7 26.7 ± 15.5***
Median 13.4 ± 19.5 29.6 ± 28.8**
Peak 0.0 ± 0.0 0.0 ± 0.0
Kappa+ % 5.5 ± 5.3 17.9 ± 20.5**
Mean 16.8 ± 23.9 83.4 ± 114.5**
Median 16.8 ± 25.7 82.9 ± 116.9**
Peak 19.9 ± 31.0 91.2 ± 124.2**
Lambda+ % 3.9 ± 3.4 16.9 ± 13.3***
Mean 30.1 ± 2.6 86.3 ± 107.3*
Median 34.5 ± 42.8 79.9 ± 98.5*
Peak 60.4 ± 73.9 90.9 ± 101.8
* p < 0.05.
** p < 0.01.
*** p < 0.001.pert’s gold standard, despite the fact that theywere initialized prop-
erly. Algorithms characterized by distance-based concepts always
tended to produce spherical clusters; thus, in complex instances
theycouldhardly identify theexisting clustering structures andesti-
mate their non trivial underlying intracluster characteristics. With
the use of Bayesian clustering, on the other hand, themodel seemed
always ﬂexible enough to correctly identify such structures, despite
the presence of the described abnormalities in data and the varying
cluster shapes, since theunderlyingparameterswere each timeesti-
mated by the EM algorithm. In fact, the obtained results appeared to
be sensitive with respect to the selected initialization parameters;
this became an advantage, since when the initial cluster thresholds
were chosen close to the suggestions of the expert (as inmanual gat-
ing or using the heuristic pre-processing step described in Section
2.1), EM algorithm always managed to approximate the ML valueustering algorithms, for a set of different ﬂow-cytometric clustering applications used
test comparing each methodology to the Bayesian clustering.
k-Medians fcm SOMs
89.9 ± 12.2*** 85.3 ± 16.9*** 96.0 ± 8.7*
88.1 ± 10.5*** 89.8 ± 11.4** 90.5 ± 7.3***
87.7 ± 17.5** 89.7 ± 14.6** 91.4 ± 7.9***
79.3 ± 9.5*** 80.2 ± 13.0*** 80.0 ± 8.9***
78.8 ± 17.3*** 78.5 ± 21.5*** 83.6 ± 14.2***
82.8 ± 12.1*** 80.3 ± 16.0*** 85.1 ± 12.0***
ken into account in B-CLL diagnosis, by a variety of clustering algorithms. The number
y to the Bayesian clustering.
k-Medians fcm SOMs
10.0 ± 12.2*** 14.6 ± 16.6*** 3.5 ± 7.1*
13.7 ± 14.3** 10.6 ± 11.5* 11.9 ± 9.5***
62.9 ± 86.6* 45.7 ± 72.3 48.7 ± 57.3**
60.2 ± 90.9* 39.6 ± 80.2 46.0 ± 64.9*
93.3 ± 132.1** 74.7 ± 121.5* 46.2 ± 82.0
38.9 ± 61.4** 36.9 ± 73.8 21.7 ± 33.1*
38.9 ± 65.5* 38.1 ± 82.9 22.1 ± 37.1
64.5 ± 104.3* 59.7 ± 116.9 22.8 ± 46.2
13.3 ± 18.1** 13.0 ± 15.3** 10.1 ± 10.2***
39.4 ± 95.2* 45.1 ± 104.5* 13.0 ± 18.0**
37.3 ± 98.8 48.7 ± 124.1* 9.9 ± 18.2*
63.5 ± 143.9* 70.0 ± 152.2* 27.9 ± 77.8
61.6 ± 122.0* 28.2 ± 48.8* 39.5 ± 73.4*
58.0 ± 124.4* 21.5 ± 35.5** 36.2 ± 76.0*
71.9 ± 123.0** 57.0 ± 106.1** 41.8 ± 82.4*
25.6 ± 15.5*** 22.4 ± 13.6*** 25.9 ± 14.4***
48.7 ± 17.5*** 45.9 ± 29.9*** 57.3 ± 20.9***
48.1 ± 34.7** 59.1 ± 48.5*** 64.6 ± 48.4***
0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
36.1 ± 14.4*** 29.2 ± 19.6*** 35.7 ± 19.5***
31.4 ± 30.7** 33.7 ± 31.2** 28.9 ± 33.7*
0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
21.7 ± 20.1*** 20.5 ± 20.6*** 23.2 ± 20.2***
90.7 ± 127.2** 73.3 ± 86.5** 75.5 ± 78.4***
92.6 ± 140.9** 70.5 ± 92.8** 64.0 ± 67.4***
107.1 ± 143.9** 114.1 ± 131.3*** 71.8 ± 85.8**
19.9 ± 13.4*** 22.2 ± 16.4*** 21.5 ± 15.5***
84.4 ± 101.4* 83.8 ± 92.1** 79.0 ± 63.1***
79.7 ± 92.0* 83.1 ± 91.0* 80.8 ± 71.4**
101.9 ± 104.3 101.3 ± 113.9 75.9 ± 81.2
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lead to accurate clustering results.
In terms of complexity, all the studied algorithmic approaches
performed sufﬁciently well. Even the largest datasets were able
to be clustered within acceptable execution times. In fact, the most
time-consuming part of the overall process was shown to be the k-
nearest neighbor method that was applied to alleviate the problem
of not having all antigens measured in the same blood sample. In
terms of efﬁciency, the algorithms with distance-based clustering
heuristics were the more efﬁcient ones, as expected; k-means, k-
medians and fuzzy c-means were executed within similar and
small times on average. On the opposite, the SOM model was theFig. 6. The application of (a) Bayesian clustering, (b) k-means and (c) SOMs in identifying
the expert’s gating. The differences on the values of various characteristic parameters cmost time-consuming approach, without however reaching unac-
ceptable levels of efﬁciency. Bayesian clustering was executed
within average times lying between these two extremes. While
the inference part of the process required negligible times as ex-
pected, the parameter learning part seemed to take a little bit long-
er. This was due to the fact, that variable clusterwas hidden and the
EM algorithm required a number of steps to converge. The time
complexity of the process depended on how close the initial EM’s
conﬁguration was to the ML conﬁguration. When EM was initial-
ized with the expert’s opinion, it was usually guaranteed that the
ML value would be approximated fast. That is, the number of
EM’s repetitions that was almost always required to yield tothe KAPPA+ subset of lymphocytes in a peripheral blood sample. Grey lines indicate
an also be observed.
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number. Thus, efﬁcient execution times were almost always
achieved by the proposed model.
A few typical examples of our clustering implementations are
presented in Figs. 4 and 5. In the former ﬁgure, we show how lym-
phocytes are distinguished in the samples of peripheral blood
using the proposed method. In the latter, we present how each
individual step of the B-CLL diagnosis procedure described in
Fig. 1 is performed with Bayesian clustering.
Tables 1 and 2 provide a comparison between all the examined
clustering algorithms. The cell labels assigned and the values of
characteristic parameters obtained by each algorithm are com-
pared to the ones produced by the expert’s gating procedure. Table
1 presents the average percentages of correctly clustered cells
(clustering scores) achieved, for a set of different ﬂow-cytometric
clustering applications used for the automated process of B-CLL
diagnosis, such as identifying lymphocytic populations or identify-
ing clusters of cells that simultaneously express two antigens.
Table 2 presents the average absolute differences obtained on the
values of various parameters taken into account by clinicians in
B-CLL diagnosis, like mean or median values of the intensities of
expressed antigens, between each clustering algorithm and the
expert. The numerical results depicted in Tables 1 and 2 would
probably be different if we incorporated the consensus from a pa-
nel of experts as our gold standard. However, since all clustering
methods examined use the same gold standard for their initializa-
tion too, we expect that the degree of alignment of each method to
the gold standard would not be signiﬁcantly different.
We conclude that Bayesian clustering yields to better cluster-
ing scores compared to every other examined approach. The dif-
ferences in the performance of the algorithms are smaller in the
initial stage of the diagnosis procedure, where lymphocytes are
identiﬁed. This happens because the clustering instances appear-
ing there, for the identiﬁcation of the B-cell and T-cell subpopu-
lations, are quite obvious and clear; thus, simple algorithms are
also able to provide near-optimal results. However, as we pro-
ceed to analysis of antigen expression, the clustering structures
become more complicated. In fact, the requested clusters are
usually non-separated, the actual number of existing clusters dif-
fers from sample-to-sample, and the optimal result is rather de-
ﬁned by what the expert expects to see, than by what any
statistical unsupervised data-driven method is able to produce.
In such instances, the difference in the performance between
Bayesian clustering and all other examined algorithms becomes
much more signiﬁcant. An example is depicted in Fig. 6, where
the clustering results produced by Bayesian clustering, k-means
and SOMs are compared with the expert’s gating, in an applica-
tion of identifying the KAPPA positive subset of lymphocytes in a
peripheral blood sample.
4. Conclusions
In the rapidly advancing ﬁeld of ﬂow cytometry, methodologies
facilitating automated clinical decision support are increasingly
needed. In the case of B-CLL, discrimination of the various subpop-
ulations of blood cells comprises an important task. The rarity of
training sets calls for the adoption of unsupervised clustering
procedures.
In this paper we have demonstrated the use of a Bayesian meth-
odology for clustering ﬂow cytometry data that addresses the inef-
ﬁciency of manually performing the vast number of intermediate
analysis steps towards the diagnosis of B-CLL. The proposed meth-
odology is able to incorporate the expert’s knowledge, as prior
information to data-driven statistical learning methods, in a simple
and efﬁcient way. Approaching the problem using probabilistic
concepts provides us with a solid foundation for future optimiza-tion of the proposed methodology and better understanding of
the parameters employed. The statistical framework of our ap-
proach can provide a safe way for extending into the rest of the
decision-making steps for the diagnosis of B-CLL.
The choice of attributes measured in a ﬂow cytometry examina-
tion may strongly affect the performance of our proposed method-
ology as well as any clustering methodology. In the diagnosis of
B-CLL, for example, FS is not an attribute able to produce an opti-
mal distinction of the lymphocyte subpopulation among the rest
of the leukocytes, while antigen attribute CD14 in combination
with SS would be. It would therefore be useful for medical doctors
to preplan a ﬂow cytometry examination and include critical (in
terms of lymphocytes gating) antigens in the same blood sample
passing through the cytometer. Flow cytometers capable of simul-
taneously registering many antigens for the same blood sample are
becoming popular; we will thus be able to treat the entire cluster-
ing problem as one clustering instance in the n-dimensional space
of attributes and perform Bayesian multidimensional clustering.
Future research for the inclusion of ﬂow cytometry data in auto-
mated procedures for clinical decision support, will require prop-
erly structured databases of clinical and laboratory data.
Applying statistical learning methodologies similar to those pre-
sented here will require large amounts of high quality data. Data
originating from diverse institutions and instruments will need
to be normalized with respect to the methodology they were ac-
quired, as well as to the instrumental parameters during acquisi-
tion. Our research group has proposed an environment for data
integration [19]. Our future efforts will aim to include automated
Bayesian clustering as a data-mining procedure within this
environment.
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